Inflammation and reduced endothelial function in the course of severe acute heart failure (Q83399881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Inflammation and reduced endothelial function in the course of severe acute heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

Acute decompensated heart failure

22 January 2020

main subject

1 reference

Stig E Hermansen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Trine Kalstad

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ole-Jakob How

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Truls Myrmel

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

12 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

117-127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Disruption of methylarginine metabolism impairs vascular homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Plasma asymmetric dimethylarginine and cardiovascular events in patients with acute decompensated heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Role of nitric oxide in the regulation of digital pulse volume amplitude in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Serum interleukin-6 and C-reactive protein are markedly elevated in acute decompensated heart failure patients with left ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Microvascular response in patients with cardiogenic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Sympathetic nervous system contributes to the age-related impairment of flow-mediated dilation of the superficial femoral artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

ATP-sensitive and inwardly rectifying potassium channels in smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Microvascular function and rheologic changes in hyperdynamic sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Acute systemic inflammation impairs endothelium-dependent dilatation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Human cytokines modulate arterial vascular tone via endothelial receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Changes of plasma asymmetric dimethylarginine levels after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Endothelin-1 and asymmetric dimethylarginine in children with left-to-right shunt after intracardiac repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.12.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2010.12.002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21316028%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference